Leveraging AI in Healthcare and Life Sciences Discussion: Join our CEO, Colin Hill at the Sixth Annual International IP Summit
We are delighted to announce that Aitia will be participating in the Sixth Annual International IP Summit. Our CEO, Colin Hill, will be a featured speaker at an engaging discussion titled: Leveraging AI in Healthcare and Life Sciences: Key Legal Considerations. Colin will be joined by industry experts Dr. Bernardo Bizzo, the Senior Director of […]
CEO and Investor Roundtable Discussion: Join our CEO, Colin Hill at BioCentury East-West Pharma Summit 2023
We are delighted to announce that Aitia will be participating in the prestigious global East-West Pharma Summit 2023 conference. Our CEO, Colin Hill, will be a featured speaker at a roundtable discussion along with industry experts Christine Aylward, the Founding & Managing Partner of Magnetic Ventures, Nathalie Beslay, the Co-founder of NAAIA, Michelle Chen, PH.D., […]
Fireside Chat: Join our CEO, Colin Hill on the Longwood Healthcare Leaders Fall Conference
We are delighted to announce that Aitia will be participating in the industry-leading Longwood Healthcare Leaders Fall Conference. Our CEO, Colin Hill, will moderate a Fireside Chat with industry experts Dave Reese, EVP R&D at Amgen and Priya Singhal, EVP & Head, Development & Interim Head of Research at Biogen. The conference focuses on a […]
GNS Healthcare Raises $23 Million Led by Cigna Ventures
Cigna Ventures taps GNS’ technology and solutions to further advance whole person health for Cigna’s customers and clients Additional partners participating in recent funding round include Amgen Ventures, Celgene Corporation, Echo Health Ventures and Alexandria Venture Investments CAMBRIDGE, Mass. – July 9, 2019 – GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 […]
GNS Healthcare Chosen to Present Discovery of New Clinical Predictors of Overall Survival in Metastatic Colorectal Cancer at ESMO 2019 in Collaboration with the Alliance for Clinical Trials in Oncology
AI-driven in silico patients used to identify heterogeneous landscape of clinical predictors of overall survival in populations of patients with metastatic colorectal cancer. CAMBRIDGE, Mass.– [July 2, 2019] – GNS Healthcare (GNS), a leading precision medicine company, together with the Alliance for Clinical Trials in Oncology (Alliance), is presenting discoveries of predictive biomarkers for metastatic colorectal cancer […]
Scott Gottlieb to Keynote GNS Healthcare’s Precision Medicine Forum
23rd FDA Commissioner to share his thoughts on the convergence of data and AI in the development and use of new medicines along with industry luminaries from biopharma, payers, and patient foundations CAMBRIDGE, Mass., June 3, 2019 /PRNewswire/ — GNS Healthcare (GNS), a leading precision medicine company, announced today that former FDA Commissioner Scott Gottlieb, […]
Iya Khalil featured in Forbes article on women making AI more accessible
May 7, 2018 –Artificial intelligence is impacting every industry so it is no wonder that this year’s Milken Global Institute focused how new technologies are changing industries, including health care. Forbes recently profiled the event, focusing on the number of women who are making artifical intelligence more accessible and less scary. The article featured Iya Khalil, co-founder […]
Roche Precision Medicine Article Features Iya Khalil
Dr. Iya Khalil, GNS chief commercial officer and co-founder, gave her perspectives on the application of machine learning to clinical trials in “Partnering in the Digital Era“, an article published by Roche this week. The precision medicine piece focuses on how collaborations between healthcare and technology companies are driving the future of healthcare and features […]
GNS Co-Founders Included on 50+ Most Influential People of Color in Life Sciences & Healthcare
GNS co-founders Colin Hill and Dr. Iya Khalil have been included on the list of the 50+ Most Influential People of Color in Life Science and Healthcare. The list, compiled by networking organization Get Konnected, was officially unveiled at an event on September 19th at the headquarters of Partners HealthCare. Earlier this year, GNS Healthcare […]
GNS Prominently Featured in BioCentury Cover Story on Use of Machine Learning by Pharma
Applying machine learning tools to drug R&D could usher in a new era of effective therapies targeting causative disease drivers, higher success rates in clinical trials and real world tools to manage adherence, prevent adverse events and reduce total healthcare costs. Download the complete article here.